Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05671380 · ClinicalTrials.gov registry record · NA
A Pragmatic Trial of Chronic Disease Approaches to Ameliorate Tobacco Related Cardiovascular Disease Health Disparities
A NA study of Cardiovascular Diseases and Smoking Cessation, sponsored by University of Minnesota.
- Active
- Registry status
- NA
- Development phase
- 700
- Enrollment target
- 3
- Study locations
NCT05671380 is a NA study of Cardiovascular Diseases and Smoking Cessation that is active but no longer recruiting, run by University of Minnesota. The registered enrollment target is 700 participants, below the 26,972-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (97% lower). The trial reports 3 study locations across 1 state.
The verdict
NCT05671380, a NA study of Cardiovascular Diseases and Smoking Cessation, is active but no longer recruiting, sponsored by University of Minnesota.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 700 participants
- Enrollment target
- 3
- Study locations
Study Summary
This project will evaluate a proactive outreach intervention for tobacco cessation among primary care BIPOC populations who smoke in two health systems across the region. Compared with Whites, BIPOC populations in the US experience disproportionate health consequences from commercial cigarette use. Few evidence-based cessation treatments (EBCTs) have been specifically developed, evaluated, or implemented for BIPOC populations. Moreover, uptake of EBCT (e.g. medication, counseling) is lower among BIPOC populations. Reasons for the failure to engage BIPOC patients in EBCTs are complex and multi-level (e.g., patient, provider, healthcare system). To address these gaps, the investigators will assess the added effectiveness of an approach to augment the standard of care with longitudinal proactive outreach to connect BIPOC adults with EBCT. The proposed multi-level intervention leverages the electronic health record to identify patients who smoke, who can then be proactively engaged via culturally tailored outreach to connect them to EBCT. The proactive approach may circumvent experiences of bias within the healthcare system and thus enhance engagement.
Conditions Studied
Interventions
- BEHAVIORAL Longitudinal Proactive Outreach (LPO).
- BEHAVIORAL Ask-Advice-Connect (AAC)
Study Locations (3)
Minnesota
- Hennepin Healthcare - Minneapolis
- University of Minnesota - Minneapolis
- Mayo Clinic Health System - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2023-05-05 |
| Est. Completion | 2026-06-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05671380
The ClinicalTrials.gov registry entry for NCT05671380 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,972-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (97% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 2 interventions - of which Longitudinal Proactive Outreach (LPO). is the first listed.
NCT05671380 reports 3 study locations spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05671380 about?
NCT05671380 is a clinical study titled "A Pragmatic Trial of Chronic Disease Approaches to Ameliorate Tobacco Related Cardiovascular Disease Health Disparities". This project will evaluate a proactive outreach intervention for tobacco cessation among primary care BIPOC populations who smoke in two health systems across the region. Compared with Whites, BIPOC populations in the US experience disproportionate health consequences from commercial cigarette use. ...
What is the current status of trial NCT05671380?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 700 participants. The study started on 2023-05-05. Estimated completion is 2026-06-24.
What conditions does trial NCT05671380 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Smoking Cessation, Smoking, Tobacco Use, Tobacco Use Cessation.
What interventions are being tested in trial NCT05671380?
The interventions under investigation include: Longitudinal Proactive Outreach (LPO). (BEHAVIORAL), Ask-Advice-Connect (AAC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05671380?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05671380 being conducted?
This trial has 3 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.